An alternative splice process renders the MLL protein either into a transcriptional activator or repressor

Pharmazie

Volumn 68, Issue 7, 2013, Pages 601-607

  Rossler T ^a   Marschalek, R ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE LEUKEMIA; ALTERNATIVE RNA SPLICING; ARTICLE; CHROMATIN; DNA METHYLATION; EPIGENETICS; EXON; FUSION GENE; HISTONE MODIFICATION; HUMAN; PROTEIN INTERACTION; PROTEIN PROCESSING;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELLS, CULTURED; EXONS; HUMANS; MOLECULAR SEQUENCE DATA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; YEASTS;

EID: 84882944319     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.6514     Document Type: Article

References (41)

1. Agrawal N, Banerjee R (2008) Human polycomb 2 protein Is a SUMO E3 ligase and alleviates substrate-induced inhibition of cystathionine ?-synthase sumoylation. PLoS ONE 3: E4032.
2. Bouyer D, Roudier F, Heese M, Andersen ED, Gey D, Nowack MK, Goodrich J, Renou JP, Grini PE, Colot V, Schnittger A (2011) Polycomb repressive complex 2 controls the embryo-to-seedling phase transition. PLoS Genet 7: E1002014.
3. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-56.
4. Bursen A, Moritz S, Gaussmann A, Moritz S, Dingermann T, Marschalek R (2004) Interaction of AF4 wild-type and AF4-MLL fusion protein with SIAH proteins: Indication for t(4;11) pathobiology? Oncogene 23: 6237-6249.
5. Bursen A, Schwabe K, Rüster B, Henschler R, Ruthardt M, Dingermann T, Marschalek R (2010) The AF4-MLL fusion protein is capable of inducing ALL in mice without requirement of MLL-AF4. Blood 115: 3570-3579.
6. Caldas C, SoCW, MacGregor A, Ford AM, McDonald B, Chan LC,Wiedemann LM (1998) Exon scrambling of MLL transcripts occur commonly and mimic partial genomic duplication of the gene. Gene 208: 167-176.
7. Chang PY, Hom RA, Musselman CA, Zhu L, Kuo A, Gozani O, Kutateladze TG, Cleary ML (2010) Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription. J Mol Biol 400: 137-144.
8. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K (2009) Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4: 80-93.
9. Eskeland R, Eberharter A, ImhofA(2007) HP1 binding to chromatin methylated atH3K9is enhanced by auxiliary factors. Mol Cell Biol 27: 453-465.
10. Fair K, Anderson M, Bulanova E, Mi H, Tropschug M, Diaz MO (2001) Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Mol Cell Biol 21: 3589-3597.
11. Gaussmann A, Wenger T, Eberle I, Bursen A, Bracharz S, Herr I, Dingermann T, Marschalek R (2007) Combined effects of the two reciprocal t(4;11) fusion proteins MLL-AF4 and AF4-MLL confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene 26: 3352-3363.
12. Grow EJ, Wysocka J (2010) Flipping MLL1's switch one proline at a time. Cell 141: 1108-1010.
13. Hom RA, Chang PY, Roy S, Musselman CA, Glass KC, Selezneva AI, Gozani O, Ismagilov RF, Cleary ML, Kutateladze TG (2010) Molecular mechanism of MLL PHD3 and RNA recognition by the Cyp33 RRM domain. J Mol Biol 400: 145-154.
14. Jin S, Zhao H, Yi Y, Nakata Y, Kalota A, Gewirtz AM (2010) c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis. J Clin Invest 120: 593-606.
15. Kato Y, Koseki H, Vidal M, Nakauchi H, Iwama A (2007) Unique composition of polycomb repressive complex 1 in hematopoietic stem cells. Int J Hematol 85: 179-181.
16. Kowarz E, Merkens J, Karas M, Dingermann T, Marschalek R (2011) Premature transcript termination, trans-splicing and DNA repair: A vicious path to cancer. Am J Blood Res 1: 1-12.
17. KuzmichevA, Margueron R,Vaquero A, Preissner TS, Scher M, Kirmizis A, Ouyang X, Brockdorff N, Abate-Shen C, Farnham P, Reinberg D (2005) Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA 102: 1859-1864.
18. Lee TI, Jenner RG, Boyer LA, GuentherMG,Levine SS,Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K, Murray HL, Zucker JP, Yuan B, BellGW, Herbolsheimer E, Hannett NM, Sun K, Odom DT, Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, Young RA (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313.
19. Linder B, Newman R, Jones LK, Debernardi S, Young BD, Freemont P, Verrijzer CP, Saha V (2000) Biochemical analyses of the AF10 protein: The extended LAP/PHD-finger mediates oligomerisation. J Mol Biol 299: 369-378.
20. Ma Q, Alder H, Nelson KK, Chatterjee D, Gu Y, Nakamura T, Canaani E, Croce CM, Siracusa LD, Buchberg AM. (1993) Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases. Proc Natl Acad Sci U S A.: 6350-6354.
21. Mbangkollo D, Burnett R, McCabe N, Thirman M, Gill H,Yu H, Rowley JD, Diaz MO (1995) The human MLL gene: Nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing. DNA Cell Biol 14: 475-483.
22. Meyer C, Kowarz E, Schneider B, Oehm C, Klingebiel T, Dingermann T, Marschalek R (2006) Genomic DNA of leukemic patients: Target for clinical diagnosis of MLL rearrangements. Biotechnol J 1: 656-663.
23. Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J, Ben Abdelali R, Macintyre E, De Braekeleer E, De Braekeleer M, Delabesse E, de Oliveira MP, Cavé H, Clappier E, van Dongen JJ, Balgobind BV, van den Heuvel-Eibrink MM, Beverloo HB, Panzer-Grümayer R, Teigler-Schlegel A, Harbott J, Kjeldsen E, Schnittger S, Koehl U, Gruhn B, Heidenreich O, Chan LC, Yip SF, Krzywinski M, Eckert C, Möricke A, Schrappe M, Alonso CN, Schäfer BW, Krauter J, Lee DA, Zur Stadt U, Te Kronnie G, Sutton R, Izraeli S, Trakhtenbrot L, Lo Nigro L, Tsaur G, Fechina L, Szczepanski T, Strehl S, Ilencikova D, Molkentin M, Burmeister T, Dingermann T, Klingebiel T, Marschalek R (2009) New insights to the MLL recombinome of acute leukemias. Leukemia 23: 1490-1499.
24. Müller J, Verrijzer P (2009) Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr Opin Genet Dev 19: 150-158.
25. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R, Dubois G, Mazo A, Croce CM, Canaani E (2002) ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 10: 1119-1128.
26. Nakata Y, Brignier AC, Jin S, Shen Y, Rudnick SI, Sugita M, Gewirtz AM (2010) c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development. Blood 116: 1280-1290.
27. Nam DK, Honoki K, Yu M, Yunis JJ (1996) Alternative RNA splicing of the MLL gene in normal and malignant cells. Gene 178: 169-175.
28. Nilson I, Löchner K, Siegler G, Greil J, Beck JD, Fey GH, Marschalek R (1996) Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. Br J Haematol 93: 966-972.
29. Park S, Osmers U, Raman G, Schwantes RH, Diaz MO, Bushweller JH (2010) The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression. Biochemistry 49: 6576-6586.
30. Reichel M, Gillert E, Angermüller S, Hensel JP, Heidel F, Lode M, Leis T, Biondi A, Haas OA, Strehl S, Panzer-Grümayer ER, Griesinger F, Beck JD, Greil J, Fey GH, Uckun FM, Marschalek R (2001) Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 20: 2900-2907.
31. Scharf S, Zech J, Bursen A, Schraets D, Oliver PL, Kliem S, Pfitzner E, Gillert E, Dingermann T, Marschalek R (2007) Transcription linked to recombination: A gene-internal promotor coincides with the recombination hot spot II of the human MLL gene. Oncogene 26: 1361-1371.
32. Schraets D, Lehmann T, Dingermann T, Marschalek R (2003) MLLmediated transcriptional gene regulation investigated by gene expression profiling. Oncogene 22: 3655-3668.
33. Schuettengruber B, Cavalli G (2009) Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice. Development 136: 3531-3542.
34. Turner BM (2002) Cellular memory and the histone code. Cell 111: 285-291.
35. Wang Z, Song J, Milne TA,Wang GG, Li H, Allis CD, Patel DJ (2010) Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell 141: 1183-1194.
36. Weishaupt H, Sigvardsson M, Attema JL (2010) Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells. Blood 115: 247-256.
37. Xia ZB, Anderson M, Diaz MO, Zeleznik-Le NJ (2003) MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci USA 100: 8342-8347.
38. Yokoyama A,Wang Z,Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W, Cleary ML (2004) Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24: 5639-5649.
39. Yokoyama A, Cleary ML (2008) Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14: 36-46.
40. Zhang Z, Jones A, Sun CW, Li C, Chang CW, Joo HY, Dai Q, Mysliwiec MR, Wu 38, Guo Y, Yang W, Liu K, Pawlik KM, Erdjument-Bromage H, Tempst P, Lee Y, Min J, Townes TM, Wang H (2011) PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells 29: 229-240.
41. ZhouW, Chen H, Zhang L (2009). The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor. BMB Rep 42: 154-159.